{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:56:14Z","timestamp":1790963774846,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.tranon.2021.101046","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T11:53:35Z","timestamp":1616327615000},"page":"101046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Diverse and converging roles of ERK1\/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-7727","authenticated-orcid":false,"given":"Akshita B.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suravi","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-1043","authenticated-orcid":false,"given":"Margarite D.","family":"Matossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-3819","authenticated-orcid":false,"given":"Erin","family":"Lexner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-5068","authenticated-orcid":false,"given":"Deniz A.","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-7287","authenticated-orcid":false,"given":"Lucio","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-3227","authenticated-orcid":false,"given":"Patrick T.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Burow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6791-3574","authenticated-orcid":false,"given":"Jane E.","family":"Cavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6024","key":"10.1016\/j.tranon.2021.101046_bib0001","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.tranon.2021.101046_bib0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.tranon.2021.101046_bib0003","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.tranon.2021.101046_bib0004","first-page":"1696","article-title":"Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis","volume":"53","author":"Oka","year":"1993","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.tranon.2021.101046_bib0005","first-page":"1731","article-title":"Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas","volume":"143","author":"Moll","year":"1993","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.tranon.2021.101046_bib0006","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-1293-1","article-title":"Triple negative breast cancer: unmet medical needs","volume":"125","author":"Pal","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.tranon.2021.101046_bib0007","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S0305-7372(10)70025-6","article-title":"Treatment of triple negative breast cancer (TNBC): current options and future perspectives","volume":"36","author":"De Laurentiis","year":"2010","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.tranon.2021.101046_bib0008","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4062\/biomolther.2012.20.3.256","article-title":"Tamoxifen resistance in breast cancer","volume":"20","author":"Chang","year":"2012","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"2","key":"10.1016\/j.tranon.2021.101046_bib0009","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijc.21355","article-title":"Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation","volume":"118","author":"Hiscox","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2021.101046_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-015-0579-y","volume":"17","author":"Yuan","year":"2015","journal-title":"Breast Cancer Res. BCR"},{"issue":"4","key":"10.1016\/j.tranon.2021.101046_bib0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S","article-title":"Phosphorylation of ERK1\/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer","volume":"95","author":"Gee","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2021.101046_bib0012","first-page":"1747","article-title":"Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression","volume":"8","author":"Adeyinka","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.tranon.2021.101046_bib0013","doi-asserted-by":"crossref","first-page":"e69291","DOI":"10.1371\/journal.pone.0069291","article-title":"MEK5\/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis","volume":"8","author":"Antoon","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.tranon.2021.101046_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2017.01.034","article-title":"Oncogenic signaling of MEK5-ERK5","volume":"392","author":"Hoang","year":"2017","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.tranon.2021.101046_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.6026\/97320630012135","article-title":"Molecular mechanisms and mode of tamoxifen resistance in breast cancer","volume":"12","author":"Ali","year":"2016","journal-title":"Bioinformation"},{"issue":"5","key":"10.1016\/j.tranon.2021.101046_bib0016","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/cas.13214","article-title":"Ets1 and ESE1 reciprocally regulate expression of ZEB1\/ZEB2, dependent on ERK1\/2 activity, in breast cancer cells","volume":"108","author":"Sinh","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.tranon.2021.101046_bib0017","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molcel.2010.02.020","article-title":"ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events","volume":"38","author":"Shin","year":"2010","journal-title":"Molecul. Cell"},{"issue":"8","key":"10.1016\/j.tranon.2021.101046_bib0018","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1242\/jcs.02308","article-title":"Activation of either ERK1\/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton","volume":"118","author":"Barros","year":"2005","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.tranon.2021.101046_bib0019","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-12-4721","article-title":"ERK1\/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition","volume":"74","author":"Buonato","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2021.101046_bib0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fonc.2019.00672","article-title":"Novel diphenylamine analogs induce mesenchymal to epithelial transition in triple negative breast cancer","volume":"9","author":"Bhatt","year":"2019","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.tranon.2021.101046_bib0021","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.bmcl.2018.05.029","article-title":"Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways","volume":"28","author":"Chakrabarty","year":"2018","journal-title":"Bioorgan. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.tranon.2021.101046_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231712","article-title":"CLCA2 expression is associated with survival among African American women with triple negative breast cancer","volume":"15","author":"Purrington","year":"2020","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.tranon.2021.101046_bib0023","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdt496","article-title":"Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival","volume":"25","author":"Bertucci","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2021.101046_bib0024","article-title":"Pharmacological inhibition of the MEK5\/ERK5 and PI3K\/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer","author":"Wright","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"3-4","key":"10.1016\/j.tranon.2021.101046_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1615\/CritRevOncog.2016016955","article-title":"Anoikis and EMT: Lethal \"Liaisons\" during cancer progression","volume":"21","author":"Cao","year":"2016","journal-title":"Crit Rev Oncog"},{"issue":"4","key":"10.1016\/j.tranon.2021.101046_bib0026","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tranon.2021.101046_bib0027","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1074\/jbc.M412599200","article-title":"The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling","volume":"280","author":"Buschbeck","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2021.101046_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2017.01.034","article-title":"Oncogenic signaling of MEK5-ERK5","volume":"392","author":"Hoang","year":"2017","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.tranon.2021.101046_bib0029","first-page":"20","article-title":"Extracellular-signal regulated kinase: a central molecule driving epithelial-mesenchymal transition in cancer","author":"Olea-Flores","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2021.101046_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-12-4721","article-title":"ERK1\/2 blockade prevents epithelial\u2013mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition","volume":"74","author":"Buonato","year":"2014","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.tranon.2021.101046_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104987","article-title":"Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2","volume":"9","author":"Smith","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.tranon.2021.101046_bib0032","doi-asserted-by":"crossref","first-page":"99","DOI":"10.18632\/oncoscience.135","article-title":"MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments","volume":"2","author":"Miranda","year":"2015","journal-title":"Oncoscience"},{"issue":"31","key":"10.1016\/j.tranon.2021.101046_bib0033","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1038\/s41388-018-0270-8","article-title":"A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis","volume":"37","author":"Pavan","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.tranon.2021.101046_bib0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"On behalf of the, E. M. T. I. A., Guidelines and definitions for research on epithelial\u2013mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.tranon.2021.101046_bib0035","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/biom10111561","article-title":"Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression","volume":"10","author":"Sinha","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.tranon.2021.101046_bib0036","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.embor.7400755","article-title":"MAPK signalling: ERK5 versus ERK1\/2","volume":"7","author":"Nishimoto","year":"2006","journal-title":"EMBO Rep"},{"issue":"42","key":"10.1016\/j.tranon.2021.101046_bib0037","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.1609019113","article-title":"ERK5 kinase activity is dispensable for cellular immune response and proliferation","volume":"113","author":"Lin","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2021.101046_bib0038","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/ml100304b","article-title":"Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1","volume":"2","author":"Deng","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.tranon.2021.101046_bib0039","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41467-020-15031-3","article-title":"Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors","volume":"11","author":"Lochhead","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.tranon.2021.101046_bib0040","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1158\/1541-7786.MCR-14-0604","article-title":"MAPK7 Regulates EMT Features and Modulates the Generation of CTCs","volume":"13","author":"Javaid","year":"2015","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.tranon.2021.101046_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01164","article-title":"ERK5 is required for tumor growth and maintenance through regulation of the extracellular matrix in triple negative breast cancer","volume":"10","author":"Hoang","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2021.101046_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117914","article-title":"Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription","volume":"10","author":"Honda","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.tranon.2021.101046_bib0043","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:45:12Z","timestamp":1761835512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1936523321000383"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101046","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diverse and converging roles of ERK1\/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101046"}}